ULURU Inc. Announces Closing Of $6,000,000 Financing

ADDISON, Texas, April 3, 2017, ULUR, /PRNewswire/ ULURU Inc. (OTCQB: ULUR), a specialty medical technology company focused on the development of a portfolio of wound management and oral drug delivery products, today announced it has completed the second closing under the Note, Warrant and Preferred Stock Purchase Agreement with Velocitas Partners, LLC and its affiliates (collectively Velocitas ) under which the Company received $6,000,000 in gross proceeds in two closings (the Financing ). The first closing, which occurred on February 27,
http://bit.ly/2oCXn8T